Skip to content
10-Q

Quarterly Report

Edgewise Therapeutics, Inc. EWTX

0001558370-25-010655

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 105.35M sh
Shares Diluted Q2 2025 · Jun 30, 2025 104.94M sh
Shares Diluted Q2 2025 · Jun 30, 2025 100.06M sh
Shares Diluted Q2 2025 · Jun 30, 2024 93.52M sh
Shares Diluted Q2 2025 · Jun 30, 2024 90.54M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$70.45M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$54.7M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $43.4M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $41.67M
Stockholders Equity Q2 2025 · Jun 30, 2025 $589.07M
Stockholders Equity Q2 2025 · Mar 31, 2025 $429.72M
Stockholders Equity Q2 2025 · Dec 31, 2024 $459.22M
Stockholders Equity Q2 2025 · Jun 30, 2024 $510.47M
Stockholders Equity Q2 2025 · Mar 31, 2024 $534.94M
Stockholders Equity Q2 2025 · Dec 31, 2023 $318.83M
Current Liabilities Q2 2025 · Jun 30, 2025 $20.9M
Current Liabilities Q2 2025 · Dec 31, 2024 $23.86M
Total Liabilities Q2 2025 · Jun 30, 2025 $24.26M
Total Liabilities Q2 2025 · Dec 31, 2024 $27.6M
Current Assets Q2 2025 · Jun 30, 2025 $603.26M
Current Assets Q2 2025 · Dec 31, 2024 $475.48M
Total Assets Q2 2025 · Jun 30, 2025 $613.33M
Total Assets Q2 2025 · Dec 31, 2024 $486.82M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.34
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.77
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.34
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.66
Eps Basic Q2 2025 · Jun 30, 2025 −$0.34
Eps Basic Q2 2025 · Jun 30, 2025 −$0.77
Eps Basic Q2 2025 · Jun 30, 2024 −$0.34
Eps Basic Q2 2025 · Jun 30, 2024 −$0.66
Sga Expense Q2 2025 · Jun 30, 2025 $9.05M
Sga Expense Q2 2025 · Jun 30, 2025 $18.25M
Sga Expense Q2 2025 · Jun 30, 2024 $7.43M
Sga Expense Q2 2025 · Jun 30, 2024 $14.49M
Rd Expense Q2 2025 · Jun 30, 2025 $33.56M
Rd Expense Q2 2025 · Jun 30, 2025 $70.32M
Rd Expense Q2 2025 · Jun 30, 2024 $30.68M
Rd Expense Q2 2025 · Jun 30, 2024 $58.37M
Net Income Q2 2025 · Jun 30, 2025 −$36.12M
Net Income Q2 2025 · Jun 30, 2025 −$76.91M
Net Income Q2 2025 · Mar 31, 2025 −$40.8M
Net Income Q2 2025 · Jun 30, 2024 −$31.5M
Net Income Q2 2025 · Jun 30, 2024 −$60.02M
Net Income Q2 2025 · Mar 31, 2024 −$28.53M
Operating Income Q2 2025 · Jun 30, 2025 −$42.61M
Operating Income Q2 2025 · Jun 30, 2025 −$88.57M
Operating Income Q2 2025 · Jun 30, 2024 −$38.11M
Operating Income Q2 2025 · Jun 30, 2024 −$72.86M
Stock Issued Q2 2025 · Apr 3, 2025 9.94M sh
Stock Issued Q2 2025 · Jan 23, 2024 21.82M sh